MaxCyte, Inc. (MXCT)
USD 2.83
(0.71%)
USD 2.83
(0.71%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 18.74 Million USD | 16.45% |
| 2022 | 16.09 Million USD | 183.26% |
| 2021 | 5.68 Million USD | -18.44% |
| 2020 | 6.96 Million USD | -3.4% |
| 2019 | 7.21 Million USD | 42.62% |
| 2018 | 5.05 Million USD | 0.51% |
| 2017 | 5.03 Million USD | 0.48% |
| 2016 | 5 Million USD | -0.74% |
| 2015 | 5.04 Million USD | 0.22% |
| 2014 | 5.03 Million USD | 170.26% |
| 2013 | 1.86 Million USD | 1.45% |
| 2012 | 1.83 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 18.52 Million USD | -0.6% |
| 2024 Q1 | 18.64 Million USD | -0.55% |
| 2023 Q2 | 16.2 Million USD | -0.28% |
| 2023 Q4 | 18.74 Million USD | 16.55% |
| 2023 FY | 18.74 Million USD | 16.45% |
| 2023 Q3 | 16.08 Million USD | -0.77% |
| 2023 Q1 | 16.25 Million USD | 0.98% |
| 2022 Q3 | 15.02 Million USD | 3.67% |
| 2022 Q4 | 16.09 Million USD | 7.13% |
| 2022 Q1 | 13.25 Million USD | 133.21% |
| 2022 Q2 | 14.49 Million USD | 9.36% |
| 2022 FY | 16.09 Million USD | 183.26% |
| 2021 Q4 | 5.68 Million USD | 429.8% |
| 2021 Q2 | 1.22 Million USD | -30.93% |
| 2021 Q1 | 1.77 Million USD | -74.58% |
| 2021 Q3 | 1.07 Million USD | -12.32% |
| 2021 FY | 5.68 Million USD | -18.44% |
| 2020 Q4 | 6.96 Million USD | 0.0% |
| 2020 FY | 6.96 Million USD | -3.4% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q2 | 6.97 Million USD | 0.0% |
| 2019 Q1 | - USD | -100.0% |
| 2019 Q4 | 7.21 Million USD | 7.59% |
| 2019 Q3 | 6.7 Million USD | 0.0% |
| 2019 FY | 7.21 Million USD | 42.62% |
| 2019 Q2 | - USD | 0.0% |
| 2018 Q1 | 5.04 Million USD | 0.32% |
| 2018 Q2 | 5.04 Million USD | 0.0% |
| 2018 FY | 5.05 Million USD | 0.51% |
| 2018 Q3 | 5.05 Million USD | 0.2% |
| 2018 Q4 | 5.05 Million USD | 0.0% |
| 2017 Q1 | 5 Million USD | 0.03% |
| 2017 FY | 5.03 Million USD | 0.48% |
| 2017 Q4 | 5.03 Million USD | 0.06% |
| 2017 Q3 | 5.02 Million USD | 0.17% |
| 2017 Q2 | 5.01 Million USD | 0.21% |
| 2016 Q1 | 4.98 Million USD | -1.25% |
| 2016 Q4 | 5 Million USD | 0.29% |
| 2016 FY | 5 Million USD | -0.74% |
| 2016 Q3 | 4.99 Million USD | -0.04% |
| 2016 Q2 | 4.99 Million USD | 0.27% |
| 2015 Q3 | 5.02 Million USD | -2.1% |
| 2015 Q1 | 5.11 Million USD | 1.58% |
| 2015 FY | 5.04 Million USD | 0.22% |
| 2015 Q4 | 5.04 Million USD | 0.33% |
| 2015 Q2 | 5.13 Million USD | 0.44% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | 5.03 Million USD | 2.97% |
| 2014 Q3 | 4.88 Million USD | 0.0% |
| 2014 FY | 5.03 Million USD | 170.26% |
| 2013 FY | 1.86 Million USD | 1.45% |
| 2012 FY | 1.83 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| PetVivo Holdings, Inc. | 1.36 Million USD | -1273.073% |
| Quanterix Corporation | 41.46 Million USD | 54.797% |
| OrthoPediatrics Corp. | 23.76 Million USD | 21.115% |
| 908 Devices Inc. | 5.94 Million USD | -215.273% |
| NanoVibronix, Inc. | 5000.00 USD | -374760.0% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -123.237% |
| BrainsWay Ltd. | 471 Thousand USD | -3879.406% |
| Cerus Corporation | 95.99 Million USD | 80.476% |
| Envoy Medical, Inc. | 404 Thousand USD | -4539.356% |
| CVRx, Inc. | 30.61 Million USD | 38.774% |
| electroCore, Inc. | 626 Thousand USD | -2894.089% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -838.793% |
| IceCure Medical Ltd | 599 Thousand USD | -3029.048% |
| Orthofix Medical Inc. | 134.19 Million USD | 86.033% |
| Inogen, Inc. | 21.92 Million USD | 14.505% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -22.865% |
| Spectral AI, Inc. | 1.28 Million USD | -1354.073% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -3709.623% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -32782.456% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -698.254% |
| Nexalin Technology, Inc. | 4463.00 USD | -419864.15% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | 52.211% |
| PAVmed Inc | 48.72 Million USD | 61.533% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -510.31% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -155.146% |
| RxSight, Inc. | 3.01 Million USD | -522.278% |
| Sight Sciences, Inc. | 35.41 Million USD | 47.075% |
| SI-BONE, Inc. | 38.99 Million USD | 51.931% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -1893.266% |
| TELA Bio, Inc. | 42.78 Million USD | 56.187% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -4979.404% |
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -1075.11% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -839.499% |
| Acutus Medical, Inc. | 38.47 Million USD | 51.29% |
| Biotricity, Inc. | 23.87 Million USD | 21.508% |
| Venus Concept Inc. | 79.69 Million USD | 76.482% |
| Bioventus Inc. | 409.47 Million USD | 95.423% |
| Nemaura Medical Inc. | 20.03 Million USD | 6.426% |
| Talis Biomedical Corporation | 19.66 Million USD | 4.703% |
| Viveve Medical, Inc. | 5.34 Million USD | -250.402% |
| LivaNova PLC | 640.4 Million USD | 97.073% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | 73.34% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -10064.317% |
| Alphatec Holdings, Inc. | 541.67 Million USD | 96.54% |
| NeuroPace, Inc. | 72.39 Million USD | 74.11% |
| LENSAR, Inc. | 2.3 Million USD | -711.737% |
| Apyx Medical Corporation | 38.5 Million USD | 51.318% |
| Cutera, Inc. | 431.91 Million USD | 95.66% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | -19.894% |
| BioSig Technologies, Inc. | 452 Thousand USD | -4046.681% |
| Anika Therapeutics, Inc. | 29.03 Million USD | 35.451% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -34.445% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | 98.885% |
| Axonics, Inc. | 27.61 Million USD | 32.132% |
| Outset Medical, Inc. | 136.18 Million USD | 86.237% |
| IRIDEX Corporation | 2.74 Million USD | -582.556% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | 76.336% |
| IRadimed Corporation | 2.04 Million USD | -817.406% |
| INVO Bioscience, Inc. | 8.68 Million USD | -115.845% |
| Telesis Bio, Inc. | 34.38 Million USD | 45.483% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -82.481% |
| Varex Imaging Corporation | 469.5 Million USD | 96.008% |
| Quipt Home Medical Corp. | 98.94 Million USD | 81.057% |
| Pulmonx Corporation | 41.42 Million USD | 54.753% |
| Dynatronics Corporation | 6.68 Million USD | -180.25% |
| Modular Medical, Inc. | 1.19 Million USD | -1475.042% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -7053.817% |
| Semler Scientific, Inc. | 70 Thousand USD | -26675.714% |
| InMode Ltd. | 9.01 Million USD | -107.863% |
| Bruker Corporation | 1.37 Billion USD | 98.641% |
| Cytosorbents Corporation | 18.31 Million USD | -2.347% |
| DexCom, Inc. | 2.59 Billion USD | 99.277% |
| Align Technology, Inc. | 96.96 Million USD | 80.671% |
| ZimVie Inc. | 521.92 Million USD | 96.409% |
| Movano Inc. | 252 Thousand USD | -7337.698% |
| Cytek Biosciences, Inc. | 33.17 Million USD | 43.501% |
| Nexalin Technology, Inc. | 4463.00 USD | -419864.15% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -838.793% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | 95.491% |
| Profound Medical Corp. | 7.9 Million USD | -137.242% |
| Insulet Corporation | 1.44 Billion USD | 98.706% |
| enVVeno Medical Corporation | 1.4 Million USD | -1236.876% |
| Surmodics, Inc. | 29.4 Million USD | 36.259% |
| iCAD, Inc. | 461 Thousand USD | -3965.727% |
| Nuwellis, Inc. | 981 Thousand USD | -1810.601% |
| iRhythm Technologies, Inc. | 129.82 Million USD | 85.563% |
| InspireMD, Inc. | 1.59 Million USD | -1075.11% |
| PAVmed Inc. | 48.72 Million USD | 61.533% |
| BIOLASE, Inc. | 17.91 Million USD | -4.651% |
| Beyond Air, Inc. | 17.83 Million USD | -5.079% |
| FONAR Corporation | 41.67 Million USD | 55.027% |
| AxoGen, Inc. | 69.29 Million USD | 72.951% |
| Vivani Medical, Inc. | 20.69 Million USD | 9.437% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | 62.793% |
| Inari Medical, Inc. | 32.04 Million USD | 41.514% |
| UFP Technologies, Inc. | 46.03 Million USD | 59.287% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -1708.58% |
| Tenon Medical, Inc. | 1.17 Million USD | -1497.869% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -1770.559% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -526.737% |
| AdaptHealth Corp. | 2.29 Billion USD | 99.183% |
| Sintx Technologies, Inc. | 4.24 Million USD | -341.531% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -698.254% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -2293.742% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | 97.993% |
| TransMedics Group, Inc. | 515.94 Million USD | 96.367% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -884.919% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -7681.182% |
| Hyperfine, Inc. | 185 Thousand USD | -10031.351% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | 90.249% |
| Biomerica, Inc. | 785 Thousand USD | -2287.643% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -4069.902% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -4964.239% |
| Silk Road Medical, Inc | 84.63 Million USD | 77.854% |